| References |
| Formal Name |
[1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl-2,4,5,6,7-d5]-1-naphthalenyl-methanone |
| Molecular Formula |
C24H17D5FNO |
| Formula Weight |
364.5 |
| Formulation |
A solution in methanol |
| Purity |
≥99% deuterated product |
| Stability |
1 year |
| Storage |
-20°C |
| Shipping |
Wet ice
in continental US; may vary elsewhere
|
| SMILES |
O=C(C1=C(C=CC=C2)C2=CC=C1)C3=C([2H])N(CCCCCF)C4=C([2H])C([2H])=C([2H])C([2H])=C43
|
| Size |
Global Purchasing |
| 500 µg |
|
| 1 mg |
|
| 5 mg |
|
| 10 mg |
|
Description
AM2201-d5 contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of AM2201 by GC- or LC-mass spectrometry. AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively.1 The physiological actions and metabolism of AM2201 have not been characterized.
1
Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives. PCT/US00/28832 1-25 (2001 Apr 26).
|
